Holen Sie sich die Stockscreener-App
0.4194
0.33%
0.0014
Handel nachbörslich:
.42
0.0006
+0.14%
Schlusskurs vom Vortag:
$0.418
Offen:
$0.4
24-Stunden-Volumen:
332.07K
Relative Volume:
0.09
Marktkapitalisierung:
$4.71M
Einnahmen:
$11.79M
Nettoeinkommen (Verlust:
$-41.04M
KGV:
-0.0123
EPS:
-33.9843
Netto-Cashflow:
$-26.29M
1W Leistung:
-16.62%
1M Leistung:
-24.25%
6M Leistung:
-75.20%
1J Leistung:
-92.59%
1-Tages-Spanne:
$0.3986
$0.4264
1-Wochen-Bereich:
$0.3986
$0.5418
52-Wochen-Spanne:
$0.3986
$14.07
Jaguar Health Inc Stock (JAGX) Company Profile
Firmenname
Jaguar Health Inc
Sektor
Branche
Telefon
415-371-8300
Adresse
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX vs VRTX, REGN, ALNY, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
0.4194 | 4.71M | 11.79M | -41.04M | -26.29M | -33.98 |
VRTX
Vertex Pharmaceuticals Inc
|
454.00 | 115.33B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
732.87 | 77.48B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.17 | 41.40B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
663.93 | 41.09B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
275.28 | 30.56B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-07-11 | Eingeleitet | Rodman & Renshaw | Buy |
Jaguar Health Inc Aktie (JAGX) Neueste Nachrichten
Will Jaguar Health Inc outperform the market in YEAR2026 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Should value investors consider Jaguar Health Inc2026 Dividend Review & AI Based Trade Execution Alerts - baoquankhu1.vn
JAGX Forecast, Price Target & Analyst Ratings | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill
Jaguar Health (JAGX) Advances Pediatric Crofelemer Study - GuruFocus
FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID) - Yahoo! Finance Canada
Published on: 2026-03-19 06:11:46 - baoquankhu1.vn
Earnings Recap: Is Jaguar Health Inc stock a top performer YTDDay Trade & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Seacoastonline.com
Jaguar Health unit begins coca extract study for weight management By Investing.com - Investing.com South Africa
Jaguar Health (JAGX) Launches Preclinical Study on Coca Leaf Ext - GuruFocus
Jaguar Health unit begins coca extract study for weight management - Investing.com
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - ACCESS Newswire
Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - FinanzNachrichten.de
Can coca leaves help keep weight off after GLP-1 drugs end? - Stock Titan
Jaguar Health, Inc. Trade Ideas — GETTEX:1JA0 - TradingView
Performance Recap: Will Jaguar Health Inc benefit from AI trends2026 Rallies & Real-Time Buy Zone Alerts - baoquankhu1.vn
Jaguar Health (NASDAQ: JAGX) asks shareholders to OK reverse splits, large potential dilution - Stock Titan
JAGX Stock Price, Quote & Chart | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill
Jaguar Health at Life Sciences Forum: Strategic Shift to Rare Diseases - Investing.com
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Sheboygan Press
Director John Micek granted stock options and RSUs at Jaguar Health (JAGX) - Stock Titan
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts - Bradenton Herald
User - The Chronicle-Journal
Published on: 2026-03-11 18:03:23 - baoquankhu1.vn
Jaguar Health (JAGX) Restructures Debt and Reduces Royalties - GuruFocus
Jaguar Health, Inc. Enters Global Amendment Agreements and Security Agreement – March 2026 8-K Filing Details - Minichart
According to the latest SEC filing, Jaguar Health Inc (NASDAQ: JAGX) has completed the amendment to the Uptown 2020 royalty interest agreement. - Bitget
Jaguar Animal Health Restructures Debt and Royalty Agreements - TipRanks
Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants - ACCESS Newswire
Jaguar Health Extends Debt, Defers Royalty Payments; Terminates 48,211-Share Warrants - TradingView
Debt extensions and warrant termination reshape Jaguar Health (NASDAQ: JAGX) - Stock Titan
Jaguar Health trims $3M in debt and royalties, extends loans to July 2026 - Stock Titan
Jaguar Health executes strategic stock exchange agreements - MSN
Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1 - ACCESS Newswire
JAGXJaguar Health Announces a Special One-time Stock Dividend - mx.advfn.com
Jaguar Health receives Nasdaq delisting notice after share price falls below $1 - Investing.com
Revenue Check: Is Jaguar Health Inc gaining market shareJuly 2025 Weekly Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
Jaguar Health Faces Nasdaq Delisting, Plans to Appeal - TipRanks
Jaguar Health Received Notice of Delisting - TradingView
Jaguar Health (NASDAQ: JAGX) confronts Nasdaq delisting risk after bid-price breach - Stock Titan
Jaguar Animal Health Declares Special Series O Dividend - The Globe and Mail
Jaguar Health receives $3M from Future Pak licensing deal By Investing.com - Investing.com India
Jaguar Health receives $3M from Future Pak licensing deal - Investing.com South Africa
Jaguar Animal Health Issues Racing Data Summary for Horses Participating in the Company’s Recently Completed Dose Determina... - mx.advfn.com
Jaguar Animal Health and Henry Schein, Inc. Sign Exclusive Distribution Agreement for Neonorm Foal - Revista ADVFN
Jaguar Health announces Series O preferred stock dividend and new certificate of designation - Investing.com Nigeria
Jaguar Health (JAGX) Secures $3M Payment From Future Pak - GuruFocus
[8-K] Jaguar Health, Inc. Reports Material Event | JAGX SEC FilingForm 8-K - Stock Titan
Jaguar Health adds $3M as it targets crofelemer for rare intestinal failure - Stock Titan
JAGX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jaguar Health, Inc.Common Stock (NQ: JAGX - The Chronicle-Journal
Finanzdaten der Jaguar Health Inc-Aktie (JAGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):